OCI NV (OCI.AS) Fundamental Analysis & Valuation

AMS:OCI • NL0010558797

Current stock price

3.606 EUR
-0.06 (-1.64%)
Last:

This OCI.AS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. OCI.AS Profitability Analysis

1.1 Basic Checks

  • In the past year OCI was profitable.
  • OCI had a negative operating cash flow in the past year.
  • Of the past 5 years OCI 4 years were profitable.
  • OCI had a positive operating cash flow in 4 of the past 5 years.
OCI.AS Yearly Net Income VS EBIT VS OCF VS FCFOCI.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B 4B

1.2 Ratios

  • OCI has a Return On Assets of 9.99%. This is amongst the best in the industry. OCI outperforms 90.28% of its industry peers.
  • OCI has a better Return On Equity (17.10%) than 86.11% of its industry peers.
Industry RankSector Rank
ROA 9.99%
ROE 17.1%
ROIC N/A
ROA(3y)40.21%
ROA(5y)27.82%
ROE(3y)65.6%
ROE(5y)55.72%
ROIC(3y)N/A
ROIC(5y)N/A
OCI.AS Yearly ROA, ROE, ROICOCI.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 100 150 200

1.3 Margins

  • Looking at the Profit Margin, with a value of 16.92%, OCI belongs to the top of the industry, outperforming 95.83% of the companies in the same industry.
  • In the last couple of years the Profit Margin of OCI has declined.
  • OCI has a worse Gross Margin (5.76%) than 88.89% of its industry peers.
  • OCI's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 16.92%
GM 5.76%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-20.23%
PM growth 5YN/A
GM growth 3Y-21.36%
GM growth 5Y-13.44%
OCI.AS Yearly Profit, Operating, Gross MarginsOCI.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 200 300 400 500

3

2. OCI.AS Health Analysis

2.1 Basic Checks

  • OCI does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, OCI has about the same amount of shares outstanding.
  • OCI has more shares outstanding than it did 5 years ago.
  • OCI has a better debt/assets ratio than last year.
OCI.AS Yearly Shares OutstandingOCI.AS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
OCI.AS Yearly Total Debt VS Total AssetsOCI.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

  • Based on the Altman-Z score of 1.43, we must say that OCI is in the distress zone and has some risk of bankruptcy.
  • OCI has a worse Altman-Z score (1.43) than 80.56% of its industry peers.
  • OCI has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.08, OCI belongs to the top of the industry, outperforming 83.33% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Altman-Z 1.43
ROIC/WACCN/A
WACC8.6%
OCI.AS Yearly LT Debt VS Equity VS FCFOCI.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B 4B

2.3 Liquidity

  • A Current Ratio of 1.34 indicates that OCI should not have too much problems paying its short term obligations.
  • OCI's Current ratio of 1.34 is on the low side compared to the rest of the industry. OCI is outperformed by 72.22% of its industry peers.
  • OCI has a Quick Ratio of 1.24. This is a normal value and indicates that OCI is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of OCI (1.24) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.34
Quick Ratio 1.24
OCI.AS Yearly Current Assets VS Current LiabilitesOCI.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2

3. OCI.AS Growth Analysis

3.1 Past

  • The earnings per share for OCI have decreased strongly by -96.31% in the last year.
  • OCI shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -47.11% yearly.
  • Looking at the last year, OCI shows a quite strong growth in Revenue. The Revenue has grown by 11.37% in the last year.
  • OCI shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -20.75% yearly.
EPS 1Y (TTM)-96.31%
EPS 3Y-47.11%
EPS 5YN/A
EPS Q2Q%-103.19%
Revenue 1Y (TTM)11.37%
Revenue growth 3Y-33.62%
Revenue growth 5Y-20.75%
Sales Q2Q%N/A

3.2 Future

  • Based on estimates for the next years, OCI will show a decrease in Earnings Per Share. The EPS will decrease by -5.80% on average per year.
  • OCI is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -6.80% yearly.
EPS Next Y-53.3%
EPS Next 2Y-43.16%
EPS Next 3Y-57.4%
EPS Next 5Y-5.8%
Revenue Next Year-0.68%
Revenue Next 2Y-22.75%
Revenue Next 3Y-17.01%
Revenue Next 5Y-6.8%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
OCI.AS Yearly Revenue VS EstimatesOCI.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B
OCI.AS Yearly EPS VS EstimatesOCI.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 4 6

5

4. OCI.AS Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 4.87, the valuation of OCI can be described as very cheap.
  • Based on the Price/Earnings ratio, OCI is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Earnings ratio of 26.77, OCI is valued rather cheaply.
  • Based on the Price/Forward Earnings ratio of 11.25, the valuation of OCI can be described as reasonable.
  • Based on the Price/Forward Earnings ratio, OCI is valued cheaply inside the industry as 87.50% of the companies are valued more expensively.
  • The average S&P500 Price/Forward Earnings ratio is at 21.75. OCI is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 4.87
Fwd PE 11.25
OCI.AS Price Earnings VS Forward Price EarningsOCI.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • OCI's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 12.18
OCI.AS Per share dataOCI.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

  • A cheap valuation may be justified as OCI's earnings are expected to decrease with -57.40% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-43.16%
EPS Next 3Y-57.4%

0

5. OCI.AS Dividend Analysis

5.1 Amount

  • OCI does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

OCI.AS Fundamentals: All Metrics, Ratios and Statistics

OCI NV

AMS:OCI (4/30/2026, 7:00:00 PM)

3.606

-0.06 (-1.64%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Industry Strength12.84
Industry Growth32.67
Earnings (Last)03-12
Earnings (Next)05-20
Inst Owners39.09%
Inst Owner ChangeN/A
Ins Owners58.66%
Ins Owner ChangeN/A
Market Cap762.16M
Revenue(TTM)1.09B
Net Income(TTM)183.70M
Analysts69.09
Price Target3.93 (8.99%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend6.77
Dividend Growth(5Y)N/A
DP911%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.94%
PT rev (3m)0.94%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.56%
Revenue NY rev (3m)-3.92%
Valuation
Industry RankSector Rank
PE 4.87
Fwd PE 11.25
P/S 0.82
P/FCF N/A
P/OCF N/A
P/B 0.83
P/tB 0.83
EV/EBITDA 12.18
EPS(TTM)0.74
EY20.52%
EPS(NY)0.32
Fwd EY8.89%
FCF(TTM)-0.82
FCFYN/A
OCF(TTM)-0.33
OCFYN/A
SpS4.39
BVpS4.34
TBVpS4.33
PEG (NY)N/A
PEG (5Y)N/A
Graham Number8.50489 (135.85%)
Profitability
Industry RankSector Rank
ROA 9.99%
ROE 17.1%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 16.92%
GM 5.76%
FCFM N/A
ROA(3y)40.21%
ROA(5y)27.82%
ROE(3y)65.6%
ROE(5y)55.72%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-20.23%
PM growth 5YN/A
GM growth 3Y-21.36%
GM growth 5Y-13.44%
F-Score4
Asset Turnover0.59
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Debt/EBITDA 0.98
Cap/Depr 115.8%
Cap/Sales 11.07%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.34
Quick Ratio 1.24
Altman-Z 1.43
F-Score4
WACC8.6%
ROIC/WACCN/A
Cap/Depr(3y)154.4%
Cap/Depr(5y)111.36%
Cap/Sales(3y)25.14%
Cap/Sales(5y)18%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-96.31%
EPS 3Y-47.11%
EPS 5YN/A
EPS Q2Q%-103.19%
EPS Next Y-53.3%
EPS Next 2Y-43.16%
EPS Next 3Y-57.4%
EPS Next 5Y-5.8%
Revenue 1Y (TTM)11.37%
Revenue growth 3Y-33.62%
Revenue growth 5Y-20.75%
Sales Q2Q%N/A
Revenue Next Year-0.68%
Revenue Next 2Y-22.75%
Revenue Next 3Y-17.01%
Revenue Next 5Y-6.8%
EBIT growth 1Y86.13%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year561.41%
EBIT Next 3Y10.37%
EBIT Next 5Y17.81%
FCF growth 1Y-237.59%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-136.79%
OCF growth 3YN/A
OCF growth 5YN/A

OCI NV / OCI.AS Fundamental Analysis FAQ

What is the ChartMill fundamental rating of OCI NV (OCI.AS) stock?

ChartMill assigns a fundamental rating of 3 / 10 to OCI.AS.


What is the valuation status of OCI NV (OCI.AS) stock?

ChartMill assigns a valuation rating of 5 / 10 to OCI NV (OCI.AS). This can be considered as Fairly Valued.


How profitable is OCI NV (OCI.AS) stock?

OCI NV (OCI.AS) has a profitability rating of 4 / 10.


How financially healthy is OCI NV?

The financial health rating of OCI NV (OCI.AS) is 3 / 10.


What is the expected EPS growth for OCI NV (OCI.AS) stock?

The Earnings per Share (EPS) of OCI NV (OCI.AS) is expected to decline by -53.3% in the next year.